wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38255698-5E424B28-6AA2-48D5-9FDB-164C4A54B803
Q38255698-5E424B28-6AA2-48D5-9FDB-164C4A54B803
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38255698-5E424B28-6AA2-48D5-9FDB-164C4A54B803
Side effects of cytokines approved for therapy.
P2860
Q38255698-5E424B28-6AA2-48D5-9FDB-164C4A54B803
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38255698-5E424B28-6AA2-48D5-9FDB-164C4A54B803
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
11e0e7414e4a9f623e44036b9676d6361f2fe0d0
P2860
XM02 is superior to placebo and equivalent to Neupogen in reducing the duration of severe neutropenia and the incidence of febrile neutropenia in cycle 1 in breast cancer patients receiving docetaxel/doxorubicin chemotherapy.